Predicting the clinical course of prostate cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15067311.
- Also identified by PMC identifier 362125.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients.
Medical subject headings
- Gene Expression Profiling
- Prostatic Neoplasms